SecProbe.io

Probe score transparency
Intelligence Terminal Search Topics Monthly Activity About

Probe Score Transparency

ImageneBio, Inc. (IMA)
Score window: Apr. 15, 2025 to Apr. 14, 2026

Probe Score
4.5 / 10
Letters
3
Latest Activity
Sep. 11, 2025
Version
v1

Score Breakdown

Letter Count
3.0
Sentiment / Tone
1.5
Keywords
0.0
Signals
0.0
Notable 8-K Modifier
0.0
Notable 8-K Count
0

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Sep. 11, 2025 CORRESP Neutral/Informational Moderate ImageneBio, Inc. has submitted a request to the SEC for the acceleration of their Registration Statement on Form S-1, seeking to have it become effective by September 15, 2025. Th… Read Filing EDGAR
Sep. 11, 2025 UPLOAD Neutral/Informational Low The SEC has communicated to ImageneBio, Inc. that they will not review the company's registration statement filed on September 8, 2025. This indicates that the SEC is not taking a… Read Filing EDGAR
Jun. 10, 2025 CORRESP Neutral/Informational Moderate Ikena Oncology, Inc. has submitted a request to the SEC for the acceleration of the effective date of their registration statement on Form S-4. They are seeking to have the regist… Read Filing EDGAR
Jun. 9, 2025 CORRESP Neutral/Informational Moderate The correspondence from Goodwin Procter, representing Ikena Oncology, Inc., addresses comments from the SEC regarding Amendment No. 4 to their Registration Statement on Form S-4. … Read Filing EDGAR
Jun. 3, 2025 UPLOAD Concern from SEC High The SEC has reviewed the amended registration statement for Ikena Oncology, Inc. and has issued comments requiring further clarification. Specifically, the SEC is seeking informat… Read Filing EDGAR
May. 7, 2025 CORRESP Neutral/Informational Moderate The correspondence from Goodwin Procter on behalf of Ikena Oncology, Inc. addresses comments from the SEC regarding their Amendment No. 1 to the Registration Statement on Form S-4… Read Filing EDGAR
May. 2, 2025 UPLOAD Concern from SEC Moderate The SEC has reviewed Ikena Oncology, Inc.'s amended registration statement and issued several comments requiring clarification and additional disclosures. Key issues include the n… Read Filing EDGAR
Apr. 21, 2025 CORRESP Neutral/Informational - No summary returned. Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.